TASCOM Co.,Ltd.
Develops SimplexTAS, a point-of-care clinical chemistry and immunoassay analyzer for IVD testing.
As of 2026-10-09, TASCOM Co.,Ltd. has 44 Korean MFDS device approvals, 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2014 and listed on KONEX in 2019, Tascom is a medical device company specializing in in vitro diagnostics (IVD). Based on immunological and biochemical biosensor technology, it develops, manufactures, and sells SimplexTAS, a point-of-care testing (POCT) device for diagnosing diabetes, hyperlipidemia, liver disease, kidney disease, infection, and other conditions. SimplexTAS uses capillary blood samples directly, removing blood cell interference through built-in centrifugation, and can analyze up to 4 samples simultaneously; it currently offers 19 developed and registered measurement-item cartridges on sale, with plans to expand to about 40.
Products & technology
- SimplexTAS (Simple Total Analysis System)Point-of-care clinical chemistry and immunoassay for diabetes, hyperlipidemia, liver disease, kidney disease, and infection
Regulatory approvals
data.go.kr44 Korean MFDS device approvals · 2016–2026
- MFDSOther Reagents, classⅡ, for clinical chemistry2026-09-21Product approval · Class 2체외 제인 26-4869 호
- MFDSreagents for clinical enzymes2026-05-06Product approval · Class 2체외 제인 26-4397 호
- MFDSreagents for clinical enzymes2026-04-30Product approval · Class 2체외 제인 26-4390 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2022-09-14Product approval · Class 2체외 제인 22-4677 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2022-09-14Product approval · Class 2체외 제인 22-4676 호
- MFDSreagents for clinical enzymesRevoked2022-09-14Product approval · Class 2체외 제인 22-4675 호
- MFDSreagents for clinical enzymes2022-09-14Product approval · Class 2체외 제인 22-4671 호
- MFDSreagents for clinical enzymesRevoked2022-09-13Product approval · Class 2체외 제인 22-4661 호
- MFDSreagents for clinical enzymes2022-09-13Product approval · Class 2체외 제인 22-4659 호
- MFDSreagents for clinical enzymes2022-09-05Product approval · Class 2체외 제인 22-4642 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2022-08-23Product approval · Class 2체외 제인 22-4614 호
- MFDSIVD reagents for anemia test2021-05-25Product approval · Class 2체외 제인 21-4446 호
Show 32 more
- MFDSIVD reagents for inflammatory tests2020-05-15Product approval · Class 2체외 제인 20-4384 호
- MFDSreagents for clinical enzymes2020-05-15Product approval · Class 2체외 제인 20-4380 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15Product approval · Class 2체외 제인 20-4377 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15Product approval · Class 2체외 제인 20-4379 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15Product approval · Class 2체외 제인 20-4381 호
- MFDSIVD reagents for diabetes mellitus2020-05-15Product approval · Class 2체외 제인 20-4382 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15Product approval · Class 2체외 제인 20-4383 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15Product approval · Class 2체외 제인 20-4385 호
- MFDSreagents for clinical enzymes2020-03-20Product approval · Class 2체외 제인 20-4221 호
- MFDSPhotometer for clinical use2020-03-03Product approval · Class 1체외 제신 20-264 호
- MFDSIVD reagents for diabetes mellitus2020-03-03Product approval · Class 2체외 제인 20-4172 호
- MFDSreagents for clinical enzymesRevoked2020-03-03Product approval · Class 2체외 제인 20-4174 호
- MFDSreagents for clinical enzymesRevoked2019-08-26Product approval · Class 2체외 제인 19-4714 호
- MFDSreagents for clinical enzymesRevoked2019-08-23Product approval · Class 2체외 제인 19-4711 호
- MFDSOther Reagents, classⅡ, for clinical chemistryRevoked2019-06-27Product approval · Class 2체외 제인 19-4516 호
- MFDSIVD reagents for electrolyte tests2019-04-22Product approval · Class 2체외 제인 19-4314 호
- MFDSreagents for clinical enzymes2018-11-09Product approval · Class 2체외 제인 18-4926 호
- MFDSreagents for clinical enzymesRevoked2018-11-09Product approval · Class 2체외 제인 18-4925 호
- MFDSreagents for clinical enzymesRevoked2018-11-09Product approval · Class 2체외 제인 18-4924 호
- MFDSIVD reagents for anemia testRevoked2018-11-08Product approval · Class 2체외 제인 18-4921 호
- MFDSIVD reagents for urine chemistry2018-11-08Product approval · Class 2체외 제인 18-4920 호
- MFDSIVD reagents for urine chemistry2018-11-08Product approval · Class 2체외 제인 18-4923 호
- MFDSIVD reagents for inflammatory testsRevoked2018-08-01Product approval · Class 2체외 제인 18-4617 호
- MFDSIVD reagents for general immune testRevoked2017-05-26Product approval · Class 2체외 제인 17-4382 호
- MFDSIVD reagents for general immune testRevoked2017-05-26Product approval · Class 2체외 제인 17-4381 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2017-05-26Product approval · Class 2체외 제인 17-4384 호
- MFDSIVD reagents for diabetes mellitusRevoked2016-12-22Product approval · Class 2체외 제인 16-988 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2016-12-22Product approval · Class 2체외 제인 16-989 호
- MFDSIVD reagents for general immune testRevoked2016-12-21Product approval · Class 2체외 제인 16-980 호
- MFDSIVD reagents for general immune testRevoked2016-12-21Product approval · Class 2체외 제인 16-981 호
- MFDSIVD reagents for general immune testRevoked2016-12-21Product approval · Class 2체외 제인 16-982 호
- MFDSPhotometer for clinical use2016-06-10Product approval · Class 1체외 제신 16-711 호
R&D and key agreements
Source: DART corporate disclosureSimplexTAS 시약카트리지 확장 · 당뇨병, 고지혈증, 간질환, 신장질환, 감염 등 · 측정항목 확장개발 중 · Currently sells cartridges for 19 measurement items, with plans to expand to about 40
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea.
Diabetes & metabolism journal · 2024-11 · Kim BJ, Shin JS, Min BH 외 16
Patents
KIPRIS · applicant-matchedUS · Published · 2024-08 · Application 18820259
US · Registered · 2022-12 · Application 18087787
US · Published · 2022-12 · Application 18083479
Rejected · 2022-03 · Application 1020220029515
Expired · 2020-04 · Application 1020200052084
Withdrawn · 2019-05 · Application 1020190064467
Withdrawn · 2019-05 · Application 1020190064466
Expired · 2018-08 · Application 1020180102803
CN · Published · 2016-06 · Application 201680046212.0
US · Registered · 2016-06 · Application 15737414
Show 6 more patents
EP · Registered · 2016-06 · Application 16811946.9
PCT · Published · 2016-06 · Application PCT/KR2016/006409
CN · Published · 2016-02 · Application 201680081260.3
US · Registered · 2016-02 · Application 16076224
EP · Registered · 2016-02 · Application 16889977.1
PCT · Published · 2016-02 · Application PCT/KR2016/001394
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot14
- GoogleGoogleOther4
- MicrosoftBingbot2
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 6, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for TASCOM Co.,Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition